Detalles de la búsqueda
1.
Adjuvant icotinib versus observation in patients with completely resected EGFR-mutated stage IB NSCLC (GASTO1003, CORIN): a randomised, open-label, phase 2 trial.
EClinicalMedicine
; 57: 101839, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36816343
2.
[Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
Zhonghua Yi Xue Za Zhi
; 89(22): 1549-52, 2009 Jun 09.
Artículo
en Zh
| MEDLINE | ID: mdl-19953883
3.
[Clinical and epidemiological features of the five kinds of new epileptic syndrome].
Zhonghua Yi Xue Za Zhi
; 86(47): 3319-23, 2006 Dec 19.
Artículo
en Zh
| MEDLINE | ID: mdl-17313825
4.
[Expression of prostaglandin transporter in colorectal cancer tissues and its relationship with clinicopathological features].
Zhonghua Wei Chang Wai Ke Za Zhi
; 18(3): 277-81, 2015 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-25809334
5.
Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model.
Sci Rep
; 4: 4324, 2014 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-24632756
6.
Discovery of potent, orally active compounds of tyrosine kinase and serine/threonine-protein kinase inhibitor with anti-tumor activity in preclinical assays.
Afr J Tradit Complement Altern Med
; 9(3): 431-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23983378
Resultados
1 -
6
de 6
1
Próxima >
>>